1. Generics Bulletin
  2. >>Products
  3. >>Generics

FDA Reveals Scale Of Perrigo Albuterol Problem

Recall Of ProAir Rival Prompted By ‘Several Thousand Complaints’

 
• By Dave Wallace

Following Perrigo’s announcement of a recall of its generic albuterol inhalers in the US, the FDA has commented on the move and has revealed that thousands of complaints have been received over the clogging problem.

Complaints
Perrigo Has Received Thousands Of Complaints Over Albuterol • Source: Shutterstock

Perrigo’s recall of its generic version of Teva’s ProAir HFA (albuterol sulfate) inhaler in the US was prompted by “several thousand complaints,” the US Food and Drug Administration has revealed in its commentary on the action.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Generics

More from Products